BIOLOGICAL THERAPY

Open Access
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial
Alessandro Consolaro, Nicolino Ruperto, Daniel J. Lovell, Olga Synoverska, Carlos Abud-Mendoza, Alberto Spindler, Yulia Vyzhga, Ekaterina Alexeeva, Jeffrey Chaitow, Peter Chiraseveenuprapund, Irina Lazariciu, Lori Stockert, Mary Jane Cadatal, Annette Diehl and Hermine I. Brunner on behalf of the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)

The Journal of Rheumatology September 1 2025, 52 (9) 919-926; DOI: https://doi.org/10.3899/jrheum.2024-0536
Open Access
Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study
Paul Emery, Roy Fleischmann, Robert Wong, Karissa Lozenski, Yoshiya Tanaka, Vivian Bykerk, Clifton O. Bingham III, Thomas W.J. Huizinga, Gustavo Citera, Vidya Perera, Bindu Murthy, Kelly Fellows Maxwell, Julie Passarell, William D. Hedrich and Daphne Williams

The Journal of Rheumatology May 1 2025, 52 (5) 426-435; DOI: https://doi.org/10.3899/jrheum.2024-0498
You have access
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study
Chiara Tani, Chiara Cardelli, Margherita Zen, Luca Moroni, Matteo Piga, Fulvia Ceccarelli, Serena Fasano, Ginevra De Marchi, Laura Coladonato, Giacomo Emmi, Mariele Gatto, Francesca Trentin, Giuseppe A. Ramirez, Elisabetta Chessa, Gabriele Gallina, Licia Picciariello, Martina Patrone, Maria L. Urban, Edoardo Biancalana, Luca Quartuccio, Francesco Ciccia, Fabrizio Conti, Alberto Cauli, Lorenzo Dagna, Andrea Doria and Marta Mosca

The Journal of Rheumatology November 1 2024, 51 (11) 1096-1101; DOI: https://doi.org/10.3899/jrheum.2024-0053
Open Access
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study
Hermine I. Brunner, César Pacheco-Tena, Ingrid Louw, Gabriel Vega-Cornejo, Ekaterina Alexeeva, Simone Appenzeller, Vyacheslav Chasnyk, Thomas Griffin, Carmen Navarrete Suarez, Sheila Knupp-Oliveira, Andrew Zeft, Yonatan Butbul Aviel, Deirdre De Ranieri, Beth S. Gottlieb, Deborah M. Levy, C. Egla Rabinovich, Clóvis Artur Silva, Yury Spivakovsky, Yosef Uziel, Sarah Ringold, Xie L. Xu, Jocelyn H. Leu, Edwin Lam, Yuhua Wang, Daniel J. Lovell, Alberto Martini and Nicolino Ruperto on behalf of the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO)

The Journal of Rheumatology November 1 2024, 51 (11) 1125-1134; DOI: https://doi.org/10.3899/jrheum.2024-0298
You have access
GRAPPA Point-Counterpoint: Should Biologics Be Used for Mild Psoriasis?
Gretchen D. Ball, Hassan Hamade, Alice B. Gottlieb, Brian Kirby and Kristina Callis Duffin

The Journal of Rheumatology October 1 2024, 51 (Suppl 2) 39-42; DOI: https://doi.org/10.3899/jrheum.2024-0655
You have access
Clinical Improvement in Early-Onset Interstitial Lung Disease Using Rituximab in Children With Antimelanoma Differentiation-Associated Gene 5–Positive Juvenile Dermatomyositis
Malki Peskin, Marilyn Mostowy, Jennifer Velez, Megan Perron, Jessica Kurian and Dawn M. Wahezi

The Journal of Rheumatology January 1 2024, 51 (1) 69-74; DOI: https://doi.org/10.3899/jrheum.2023-0544
You have access
Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years
Ingrid M. Visman, Sadaf Atiqi, Maarten Boers, Jos W.R. Twisk and Michael T. Nurmohamed

The Journal of Rheumatology January 1 2024, 51 (1) 84-87; DOI: https://doi.org/10.3899/jrheum.2023-0149
Open Access
Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials
Nicolino Ruperto, Daniel J. Lovell, Alberto Berman, Jordi Anton, Diego O. Viola, Bernard Lauwerys, Maria E. Rama, John Bohnsack, Johannes Breedt, Michel Fischbach, Thomas Lutz, Kirsten Minden, Mahmood Ally, Nadina Rubio-Pérez, Elisabeth Gervais, Riana Van Zyl, Robert Wong, Margarita Askelson, Alberto Martini and Hermine I. Brunner for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO)

The Journal of Rheumatology November 1 2023, 50 (11) 1471-1480; DOI: https://doi.org/10.3899/jrheum.2022-1320
You have access
Can Early Aggressive Treatment of Psoriasis Prevent Psoriatic Arthritis? A Debate at the GRAPPA Annual Meeting
Enrique R. Soriano and Alexis Ogdie

The Journal of Rheumatology November 1 2023, 50 (Suppl 2) 8-10; DOI: https://doi.org/10.3899/jrheum.2023-0506
Open Access
Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program
Atul Deodhar, Denis Poddubnyy, Proton Rahman, Jeorg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araújo, Ann Leung and Désirée van der Heijde

The Journal of Rheumatology August 1 2023, 50 (8) 1020-1028; DOI: https://doi.org/10.3899/jrheum.221022

Main menu

User menu

Search

BIOLOGICAL THERAPY

Pages

Content

Resources

Subscribers

More